BRIEF published on 04/23/2024 at 13:05, 1 year 7 months ago Roam Partners with Veritree to Combat Car Subscription Emissions Emissions Reduction Reforestation Roam Veritree Car Subscription
BRIEF published on 04/23/2024 at 13:05, 1 year 7 months ago Roam s'associe à Veritree pour lutter contre les émissions des abonnements automobiles Réduction Des Émissions Reboisement Veritree Errer Abonnement Voiture
PRESS RELEASE published on 04/23/2024 at 13:00, 1 year 7 months ago Roam and veritree Launch Partnership to Reduce Car Subscription Emissions Roam, Canada's car subscription company, partners with veritree for a reforestation initiative to offset emissions. Leading sustainability in the automotive industry Sustainability Émissions Reforestation Roam Car Subscription
PRESS RELEASE published on 10/18/2023 at 14:00, 2 years 1 month ago Roam Launches Private Car-Sharing Solution for Real Estate Developers
Published on 12/05/2025 at 02:35, 4 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 27 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 12 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
